Additional red blood cell alloantibodies after blood transfusions in a nonhematologic alloimmunized patient cohort: is it time to take precautionary measures?
about
The Influence of Clinical and Biological Factors on Transfusion-Associated Non-ABO Antigen Alloimmunization: Responders, Hyper-Responders, and Non-RespondersHaemoglobin disorders in Australia: where are we now and where will we be in the future?The Impact of Extended Typing On Red Blood Cell Alloimmunization in Transfused PatientsImmunoregulatory networks in sickle cell alloimmunization.Hemin controls T cell polarization in sickle cell alloimmunization.Prevalence and Specificity of RBC Alloantibodies in Indian Patients Attending a Tertiary Care Hospital.Red blood cell antibodies in thalassemia patients in northern India: risk factors and literature review.Transfusion in the absence of inflammation induces antigen-specific tolerance to murine RBCs.Alloimmunization screening after transfusion of red blood cells in a prospective studyComments on: Alloimmunization screening after transfusion of red blood cells in a prospective studyRegulatory T-cell status in red cell alloimmunized responder and nonresponder miceMolecular matching of red blood cells is superior to serological matching in sickle cell disease patientsRed Cell Alloantibodies in Multiple Transfused Thalassaemia Patients.HLA alloimmunization is associated with RBC antibodies in multiply transfused patients with sickle cell disease.Frequency & specificity of RBC alloantibodies in patients due for surgery in Iran.Molecular immunohaematology round table discussions at the AABB Annual Meeting, Anaheim 2015Molecular testing in transfusion medicine.Red blood cell alloimmunization in sickle cell disease and in thalassaemia: current status, future perspectives and potential role of molecular typing.Red blood cell alloimmunization in patients with sickle cell disease: correlation with HLA and cytokine gene polymorphisms.Immune Regulation of sickle Cell Alloimmunization.Alloimmunization to Red Cells and the Association of Alloantibodies Formation with Splenectomy Among Transfusion-Dependent β-Thalassemia Major/HbE Patients.Will Genotyping Replace Serology in Future Routine Blood Grouping? - Opinion 5.Duffy and kidd genotyping facilitates pretransfusion testing in patients undergoing long-term transfusion therapy.The severity of illness and inflammatory markers cannot predict red blood cell alloimmunization in cancer patients.How we incorporate molecular typing of donors and patients into our hospital transfusion service.Effect of screening for red cell antibodies, other than anti-D, to detect hemolytic disease of the fetus and newborn: a population study in the Netherlands.A uniform method for the simultaneous blood group phenotyping of Fy(a) , Fy(b) , Jk(a) , Jk(b) , S, s̅, P1, k applying lateral-flow technique.Occurrence of five distinct red cell alloantibodies in a renal transplant recipient: Diagnostic and therapeutic implications of minor histocompatibility antigens (Kidd and Duffy) for renal allograft outcome.HLA polymorphisms and risk of red blood cell alloimmunisation in polytransfused patients with sickle cell anaemia.Determinants of red blood cell alloantibody detection duration: analysis of multiply alloimmunized patients supports peritransfusion factors.The HLA-DRB1*15 phenotype is associated with multiple red blood cell and HLA antibody responsiveness.Phenotyping Rh/Kell and risk of alloimmunization in haematological patients.Incidence of alloantibody formation after ABO-D or extended matched red blood cell transfusions: a randomized trial (MATCH study).Granulocyte-reactive antibodies are associated with red blood cell alloimmunization.HLA-DRB1 associations in individuals with single and multiple clinically relevant red blood cell antibodies.Red-blood-cell alloimmunization and number of red-blood-cell transfusions.Rh and Kell Phenotype Matched Blood Versus Randomly Selected and Conventionally Cross Matched Blood on Incidence of Alloimmunization.Does an alloimmune response to strong immunogenic red blood cell antigens enhance a response to weaker antigens?Determination of 24 minor red blood cell antigens for more than 2000 blood donors by high-throughput DNA analysis.Platelet Transfusion Induces Alloimmunization to D and Non-D Rhesus Antigens.
P2860
Q27000807-48CE9EEC-F852-4585-BC89-6A99C25202B3Q30251663-512624EB-1515-40E5-A43D-FAC9426C6DA9Q33646037-FBC916DC-7873-4071-A46A-3E6DE930312DQ33667429-4C1CD356-C3A7-478D-83A1-CCCAACB9E922Q33797355-8FDC4B3C-04FA-4451-837B-13BF64D6BE75Q34438140-12794886-E393-430C-9E88-3BC9B868A64EQ34569009-1582754C-8B45-42C6-BC0F-78460EA4990FQ35776447-E7FC749D-882E-4FCC-929D-4664F96C5749Q36283860-8DD583B4-44C7-4DED-89E9-AB1DD35EA309Q36283865-C84A4038-5DD0-45C4-9A30-7FD0F4BB9404Q36510060-C5026434-2A2A-499A-AA89-301CCE89371DQ36753265-588C035A-F758-4FF7-8A79-9E245B024B0BQ37037139-0E5872DE-A832-49F2-BBED-8865CE2A99DEQ37044218-931F9A04-D076-4C97-BDF9-12848CA6B21BQ37210285-C7D9D467-F3CB-415F-AD9F-83A841DC77C6Q37417326-11D6F69B-FAFC-422B-B17D-A733AF383D3EQ38089886-39C76A76-F2BD-40E7-AF3B-07C26B71ED04Q38151829-F6F41830-51CB-4A18-9504-0B34177060B6Q38792156-BCEB9592-BD11-49F4-965E-9D56009EF775Q38928447-977832A5-C94E-4E90-8C6A-AE4D0FB938E8Q39516644-ADA3562C-CD0C-40C1-8762-CC2E9BDA89F9Q40014394-F44C64CA-0C5D-4624-8CE0-B973B441DD50Q41820533-995C22DE-C8EE-4980-9444-D9172960F39EQ41898269-71A56E70-82B8-486C-A6C5-18D452D88B9BQ44479896-DF98FA3F-8AD4-40B2-A314-551080BA5B9BQ46337268-CF17C275-960E-449A-ABB8-5AA88889C953Q48169592-CFB91A2F-1A39-4363-A54C-9EE2238B0D7AQ50195471-E2A96526-8DC1-496D-BAAF-13CF704A9AA2Q50197445-7BB24D47-6D44-4180-AC9E-5C59CB78D62DQ50204408-2069000A-6442-4D11-91D1-B4803D095186Q50239998-B16C7CF6-C9A6-44FC-83EB-73E10887866DQ50271295-8BC84282-ABDB-46B9-8A1B-80D64A4C652FQ50435948-9ED31730-9341-494F-97BB-C7F6C06A7F29Q50474554-53261FA7-B447-4A24-AA57-09FB37AD5D5BQ50476222-A746337B-DA35-4A15-9FD5-16BFE28521F7Q50530319-A6C56641-F9B1-4A8D-A8AA-2E2E3DA2AA0FQ50594154-6C280A03-3CDA-42E5-8F4F-C7A1AAFC276DQ50650747-C40D8C1A-A578-4051-93F0-EC77BFB661BEQ50701292-111E54DC-DDC0-4F21-9027-067822C82B33Q55240770-57905D8D-0EB9-4B44-84F0-BDFF11AB71FE
P2860
Additional red blood cell alloantibodies after blood transfusions in a nonhematologic alloimmunized patient cohort: is it time to take precautionary measures?
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Additional red blood cell allo ...... o take precautionary measures?
@en
type
label
Additional red blood cell allo ...... o take precautionary measures?
@en
prefLabel
Additional red blood cell allo ...... o take precautionary measures?
@en
P2093
P2860
P1433
P1476
Additional red blood cell allo ...... o take precautionary measures?
@en
P2093
Anneke Brand
Henk Schonewille
Leo M G van de Watering
P2860
P304
P356
10.1111/J.1537-2995.2006.00764.X
P577
2006-04-01T00:00:00Z